Breast-Cancer Adjuvant Therapy with Zoledronic Acid

Research output: Contribution to journalArticleAcademicpeer-review

37 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)188-189
JournalNew England Journal of Medicine
Volume366
Issue number2
DOIs
Publication statusPublished - 2012

Cite this

@article{544eac98139e44f1a27b76f415c15d86,
title = "Breast-Cancer Adjuvant Therapy with Zoledronic Acid",
author = "{van der Vliet}, J.J. and H.M.W. Verheul",
year = "2012",
doi = "10.1056/nejmc1113049",
language = "Undefined/Unknown",
volume = "366",
pages = "188--189",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "2",

}

Breast-Cancer Adjuvant Therapy with Zoledronic Acid. / van der Vliet, J.J.; Verheul, H.M.W.

In: New England Journal of Medicine, Vol. 366, No. 2, 2012, p. 188-189.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Breast-Cancer Adjuvant Therapy with Zoledronic Acid

AU - van der Vliet, J.J.

AU - Verheul, H.M.W.

PY - 2012

Y1 - 2012

U2 - 10.1056/nejmc1113049

DO - 10.1056/nejmc1113049

M3 - Article

VL - 366

SP - 188

EP - 189

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 2

ER -